Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
While Medicaid and Medicare do not cover semaglutide prescriptions for other weight loss medications, Medicare Part D may cover it when prescribed for type 2 diabetes treatment
That compares with 280,000 weekly Wegovy users
Some offer a bare-bones prescription service, while others, like us, provide a comprehensive, clinician-guided journey
The medical assessment process begins with comprehensive online questionnaires covering complete medical history including previous diagnoses, surgeries, hospitalizations, and chronic conditions, detailed current medication lists with doses and schedules, family medical history with particular attention to thyroid disorders and endocrine cancers, weight history including highest and lowest adult weights and previous weight loss attempts, metabolic health markers including blood sugar control and cardiovascular status, and lifestyle factors including dietary patterns, physical activity levels, sleep quality, and stress management
PLOS Glob Public Health 5:e0005516
Developer: Eli Lilly and Company | Administration in Trials: Once-weekly subcutaneous injection First successful Phase 3 trial (TRIUMPH-4, topline Dec 2025): Up to 28.7% average body weight loss at 68 weeks (highest dose) in adults with obesity/overweight and knee osteoarthritis
US$ 26.88
.webp)
US$ 25.32
US$ 23.23
US$ 24.58
US$ 21.34
US$ 24.10
US$ 22.52
US$ 25.53
